These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis. Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies. Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies]. Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666 [TBL] [Abstract][Full Text] [Related]
6. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M; Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308 [TBL] [Abstract][Full Text] [Related]
7. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience. Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248 [TBL] [Abstract][Full Text] [Related]
8. The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance. Mehtat Ünlü Ş; Özsan H; Sarıoğlu S Turk J Haematol; 2017 Dec; 34(4):282-288. PubMed ID: 28832010 [TBL] [Abstract][Full Text] [Related]
9. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China. Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197 [TBL] [Abstract][Full Text] [Related]
10. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature]. Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442 [TBL] [Abstract][Full Text] [Related]
11. [Renal manifestations of light chain associated diseases - epidemiology and prognosis]. Gerth J; Sigusch H; Illner N; Busch M; Muegge LO; Lehmann T; Wolf G Dtsch Med Wochenschr; 2013 Feb; 138(7):305-12. PubMed ID: 23392999 [TBL] [Abstract][Full Text] [Related]
13. [Clinical Features of 46 Multiple Myeloma Patients with Different Renal Pathology]. Su YT; Xie XS; Sun H; Ma J; Wan DM; Liu YF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):487-91. PubMed ID: 27151016 [TBL] [Abstract][Full Text] [Related]
14. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754 [TBL] [Abstract][Full Text] [Related]
15. [Classification and therapeutic management of monoclonal gammopathies of renal significance]. Javaugue V; Bouteau I; Sirac C; Quellard N; Diolez J; Colombo A; Desport E; Ecotière L; Goujon JM; Fermand JP; Touchard G; Jaccard A; Bridoux F Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients. Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418 [TBL] [Abstract][Full Text] [Related]
17. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis. Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744 [TBL] [Abstract][Full Text] [Related]
18. Primary systemic amyloidosis with delayed progression to multiple myeloma. Rajkumar SV; Gertz MA; Kyle RA Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527 [TBL] [Abstract][Full Text] [Related]
19. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist. Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059 [TBL] [Abstract][Full Text] [Related]
20. [Survival of myeloma patients treated with dialysis]. Martín Reyes G; Valera A; Frutos MA; Ramos B; Ordóñez V; López de Novales E Nefrologia; 2003; 23(2):131-6. PubMed ID: 12778877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]